_id

690f356cccc777a4e85d16e2

Ticker

BIOR

Name

Biora Therapeutics Inc

Exchange

OTCMKTS

Address

4330 La Jolla Village Drive, San Diego, CA, United States, 92122

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.bioratherapeutics.com

Description

Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California. On December 27, 2024, Biora Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Last Close

0.22

Volume

169446

Current Price

0.22

Change

0

Last Updated

2025-11-28T12:54:15.025Z

Image

data:image/webp;base64,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

Ipo Date

2020-06-19T00:00:00.000Z

Market Cap

994994

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Rating

4

Target Price

34

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2024-09-30

Revenue

32000

Cost Of Revenue

-

Gross Profit

32000

Operating Expenses

16259000

Operating Income

-16227000

Interest Expense

2016000

Pretax Income

-22262000

Net Income

-18402000

Eps

-5.037693731654795

Dividends Per Share

-

Shares Outstanding

4522700

Income Tax Expense

-44000

EBITDA

-20135000

Operating Margin

-50709.375

Total Other Income Expense Net

-6035000

Cash

3196000

Short Term Investments

-

Receivables

868000

Inventories

-

Total Current Assets

6054000

Property Plant Equipment

2186000

Total Assets

14505000

Payables

6916000

Short Term Debt

24965000

Long Term Debt

-

Total Liabilities

121134000

Equity

-106629000

Depreciation

-369000

Change In Working Capital

32961000

Cash From Operations

31823000

Capital Expenditures

19000

Cash From Investing

-

Cash From Financing

6620000

Net Change In Cash

-2129000

PE

0.6111

PB

-0.007536689268397903

ROE

17.257969220380946

ROA

-126.86659772492244

FCF

31804000

Fcf Percent

993.875

Piotroski FScore

2

Health Score

48

Deep Value Investing Score

6.5

Defensive Investing Score

5.5

Dividend Investing Score

3

Economic Moat Investing Score

7.8

Garp Investing Score

3.5

Growth Investing Score

3.5

Momentum Investing Score

4

Net Net Investing Score

3.5

Quality Investing Score

3.5

Value Investing Score

5

Quarters > 0 > quarter

2024-09-30

Quarters > 0 > income Statement > revenue

32000

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

32000

Quarters > 0 > income Statement > operating Expenses

16259000

Quarters > 0 > income Statement > operating Income

-16227000

Quarters > 0 > income Statement > interest Expense

2016000

Quarters > 0 > income Statement > pretax Income

-22262000

Quarters > 0 > income Statement > net Income

-18402000

Quarters > 0 > income Statement > eps

-5.037693731654795

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

3652862

Quarters > 0 > income Statement > income Tax Expense

-44000

Quarters > 0 > income Statement > EBITDA

-20135000

Quarters > 0 > income Statement > operating Margin

-50709.375

Quarters > 0 > income Statement > total Other Income Expense Net

-6035000

Quarters > 0 > balance Sheet > cash

3196000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

868000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

6054000

Quarters > 0 > balance Sheet > property Plant Equipment

2186000

Quarters > 0 > balance Sheet > total Assets

14505000

Quarters > 0 > balance Sheet > payables

6916000

Quarters > 0 > balance Sheet > short Term Debt

24965000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

121134000

Quarters > 0 > balance Sheet > equity

-106629000

Quarters > 0 > cash Flow > net Income

90555000

Quarters > 0 > cash Flow > depreciation

-369000

Quarters > 0 > cash Flow > change In Working Capital

32961000

Quarters > 0 > cash Flow > cash From Operations

31823000

Quarters > 0 > cash Flow > capital Expenditures

19000

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

6620000

Quarters > 0 > cash Flow > net Change In Cash

-2129000

Quarters > 0 > ratios > PE

-5.037693731654795

Quarters > 0 > ratios > PB

-0.007536689268397903

Quarters > 0 > ratios > ROE

17.257969220380946

Quarters > 0 > ratios > ROA

-126.86659772492244

Quarters > 0 > ratios > FCF

31804000

Quarters > 0 > ratios > Piotroski FScore

2

Quarters > 0 > ratios > fcf Percent

993.875

Quarters > 0 > health Score

48

Quarters > 1 > quarter

2024-06-30

Quarters > 1 > income Statement > revenue

318000

Quarters > 1 > income Statement > cost Of Revenue

110000

Quarters > 1 > income Statement > gross Profit

208000

Quarters > 1 > income Statement > operating Expenses

16104000

Quarters > 1 > income Statement > operating Income

-15786000

Quarters > 1 > income Statement > interest Expense

711000

Quarters > 1 > income Statement > pretax Income

6398000

Quarters > 1 > income Statement > net Income

6465000

Quarters > 1 > income Statement > eps

0.00008711063248396043

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

74215969000

Quarters > 1 > income Statement > income Tax Expense

-67000

Quarters > 1 > income Statement > EBITDA

7218999

Quarters > 1 > income Statement > operating Margin

-4964.1509433962265

Quarters > 1 > income Statement > total Other Income Expense Net

22184000

Quarters > 1 > balance Sheet > cash

5325000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

822000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

9201000

Quarters > 1 > balance Sheet > property Plant Equipment

2485000

Quarters > 1 > balance Sheet > total Assets

18263000

Quarters > 1 > balance Sheet > payables

7512000

Quarters > 1 > balance Sheet > short Term Debt

2794000

Quarters > 1 > balance Sheet > long Term Debt

43765000

Quarters > 1 > balance Sheet > total Liabilities

107585000

Quarters > 1 > balance Sheet > equity

-89322000

Quarters > 1 > cash Flow > net Income

6465000

Quarters > 1 > cash Flow > depreciation

110000

Quarters > 1 > cash Flow > change In Working Capital

3397000

Quarters > 1 > cash Flow > cash From Operations

-10952000

Quarters > 1 > cash Flow > capital Expenditures

180000

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

5637000

Quarters > 1 > cash Flow > net Change In Cash

-5495000

Quarters > 1 > ratios > PE

0.00008711063248396043

Quarters > 1 > ratios > PB

-182.7938601912183

Quarters > 1 > ratios > ROE

-7.2378585342916635

Quarters > 1 > ratios > ROA

35.39944149373049

Quarters > 1 > ratios > FCF

-11132000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-35.0062893081761

Quarters > 1 > health Score

39

Quarters > 2 > quarter

2024-03-31

Quarters > 2 > income Statement > revenue

542000

Quarters > 2 > income Statement > cost Of Revenue

105000

Quarters > 2 > income Statement > gross Profit

437000

Quarters > 2 > income Statement > operating Expenses

16058000

Quarters > 2 > income Statement > operating Income

-15516000

Quarters > 2 > income Statement > interest Expense

2757000

Quarters > 2 > income Statement > pretax Income

-4141000

Quarters > 2 > income Statement > net Income

-4189000

Quarters > 2 > income Statement > eps

-0.14298506043346013

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

29296767

Quarters > 2 > income Statement > income Tax Expense

48000

Quarters > 2 > income Statement > EBITDA

-1279000

Quarters > 2 > income Statement > operating Margin

-2862.730627306273

Quarters > 2 > income Statement > total Other Income Expense Net

11375000

Quarters > 2 > balance Sheet > cash

10820000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

822000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

14071000

Quarters > 2 > balance Sheet > property Plant Equipment

2554000

Quarters > 2 > balance Sheet > total Assets

22990000

Quarters > 2 > balance Sheet > payables

4936000

Quarters > 2 > balance Sheet > short Term Debt

2896000

Quarters > 2 > balance Sheet > long Term Debt

43278000

Quarters > 2 > balance Sheet > total Liabilities

123175000

Quarters > 2 > balance Sheet > equity

-100185000

Quarters > 2 > cash Flow > net Income

-4189000

Quarters > 2 > cash Flow > depreciation

105000

Quarters > 2 > cash Flow > change In Working Capital

2248000

Quarters > 2 > cash Flow > cash From Operations

-12496000

Quarters > 2 > cash Flow > capital Expenditures

15000

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

5100000

Quarters > 2 > cash Flow > net Change In Cash

-4391000

Quarters > 2 > ratios > PE

-0.14298506043346013

Quarters > 2 > ratios > PB

-0.06433386974097918

Quarters > 2 > ratios > ROE

4.1812646603783

Quarters > 2 > ratios > ROA

-18.22096563723358

Quarters > 2 > ratios > FCF

-12511000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-23.083025830258304

Quarters > 2 > health Score

18

Quarters > 3 > quarter

2023-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

13344000

Quarters > 3 > income Statement > operating Income

-13344000

Quarters > 3 > income Statement > interest Expense

1840000

Quarters > 3 > income Statement > pretax Income

-15727000

Quarters > 3 > income Statement > net Income

-15413000

Quarters > 3 > income Statement > eps

-0.6212183238809778

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

24810923

Quarters > 3 > income Statement > income Tax Expense

-95000

Quarters > 3 > income Statement > EBITDA

-13125000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

-2383000

Quarters > 3 > balance Sheet > cash

15211000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

830000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

19071000

Quarters > 3 > balance Sheet > property Plant Equipment

2770000

Quarters > 3 > balance Sheet > total Assets

31215000

Quarters > 3 > balance Sheet > payables

2843000

Quarters > 3 > balance Sheet > short Term Debt

1976000

Quarters > 3 > balance Sheet > long Term Debt

43736000

Quarters > 3 > balance Sheet > total Liabilities

132636000

Quarters > 3 > balance Sheet > equity

-101421000

Quarters > 3 > cash Flow > net Income

-15413000

Quarters > 3 > cash Flow > depreciation

117000

Quarters > 3 > cash Flow > change In Working Capital

-799000

Quarters > 3 > cash Flow > cash From Operations

-13745000

Quarters > 3 > cash Flow > capital Expenditures

66000

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

13918000

Quarters > 3 > cash Flow > net Change In Cash

2642000

Quarters > 3 > ratios > PE

-0.6212183238809778

Quarters > 3 > ratios > PB

-0.05381925893059623

Quarters > 3 > ratios > ROE

15.197049920627878

Quarters > 3 > ratios > ROA

-49.37690213038603

Quarters > 3 > ratios > FCF

-13811000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

35

Valuation > metrics > PE

0.6111

Valuation > metrics > PB

-0.007536689268397903

Valuation > final Score

70

Valuation > verdict

93.9% Undervalued

Profitability > metrics > ROE

17.257969220380946

Profitability > metrics > ROA

-303.9643211100099

Profitability > metrics > Net Margin

-575.0625

Profitability > final Score

35

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-8.049107142857142

Risk > final Score

-2

Risk > verdict

High

Liquidity > metrics > Current Ratio

0.18989366707443306

Liquidity > metrics > Quick Ratio

0.18989366707443306

Liquidity > final Score

19

Liquidity > verdict

Weak

Prev Valuations > 0

70

Prev Valuations > 1

50

Prev Valuations > 2

50

Prev Profitabilities > 0

60

Prev Profitabilities > 1

8

Prev Profitabilities > 2

45

Prev Risks > 0

-59

Prev Risks > 1

7

Prev Risks > 2

1

Prev Liquidities > 0

55

Prev Liquidities > 1

95

Prev Liquidities > 2

100

Updated At

2025-12-14T00:16:46.300Z